The reinstatement model and relapse prevention: a clinical perspective
- First Online:
- 262 Downloads
This commentary assesses the degree to which the reinstatement model is homologous to the human experience of relapse.
A review of the literature suggests that the relationship is less clear than is often assumed, largely due to a lack of prospective data on the precipitants and process of relapse (especially relapse to heroin or cocaine abuse). However, reinstatement does not need to resemble relapse to have immediate clinical value; predictive validity as a medication screen would be sufficient. Whether the model has predictive validity is unknown, because, to date, very few clinical trials have tested medications that are effective in the reinstatement model, and even fewer have used designs comparable to those of reinstatement experiments. A clinical trial comparable to a reinstatement experiment would enroll participants who are already abstinent, and its main outcome measure would be propensity to undergo a specific type of relapse (e.g., relapse induced by stress or cues).
Until clinical and preclinical work are more comparable, criticisms of the reinstatement model's presumed shortcomings are premature.
- Bergman J, Katz JL (1998) Behavioral pharmacology of cocaine and the determinants of abuse liability. In: Higgins ST, Katz JL (eds) Cocaine abuse: Behavior, pharmacology, and clinical applications. Academic Press, San Diego, pp 51–79Google Scholar
- CRISP Database Of Federally Funded Biomedical Research Projects (2003) http://crisp.cit.nih.gov. Cited 13 Feb 2003Google Scholar
- Freedman M, Pulley L, Abdolrussa B, McNamara C, Milby J, Schumacher J (2002) Ecological momentary assessment of crack cocaine relapse risk. In: 64th annual scientific meeting of the college on problems of drug dependence, San Juan, Puerto Rico. http://biopsych.com:81/cpdd02_web. Cited 13 Feb 2003Google Scholar
- Gallin JI, Gottesman MM (2003) Bench-to-bedside awards. National Institutes of Health, Bethesda, MD. http://www.cc.nih.gov/ccc/btb/awards.html. Cited 10 March 2003Google Scholar
- Gosnell BA (2000) The effects of sucrose availability on the reinstatement of cocaine-seeking. Soc Neurosci Abstr 485.16Google Scholar
- Grimm JW, Hope BT, Wise RA, Shaham Y (2001) Neuroadaptation: incubation of cocaine craving after withdrawal. Nature 412:141–142Google Scholar
- Hays JT, Hurt RD, Rigotti NA, Niaura R, Gonzales D, Durcan MJ, Sachs DPL, Wolter TD, Buist AS, Johnston JA, White JD (2001) Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation: a randomized, controlled trial. Ann Intern Med 135:423–433CrossRefPubMedGoogle Scholar
- Hiller ML (1996) Correlates of recidivism and relapse for parolees who received in-prison substance abuse treatment in Texas. In: Dissertation abstracts international: Section b: The sciences and engineering, vol 57(4-B):2866 Univ Microfilms International, USAGoogle Scholar
- Lê AD, Poulos CX, Harding S, Watchus J, Juzytsch W, Shaham Y (1999) Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress. Neuropsychopharmacology 21:435–444CrossRefPubMedGoogle Scholar
- Marlatt AG (1996) Models of relapse and relapse prevention: a commentary. Exp Clin Psychopharmacol 4:55–60Google Scholar
- Montoya ID, Gorelick DA, Preston KL, Umbricht A, Cheskin L, Contoreggi C, Johnson RE, Fudala PJ (1996) Buprenorphine for treatment of dually-dependent (opiate and cocaine) individuals. NIDA Research Monograph 162:178Google Scholar
- Nader MA, Woolverton WL (1991) Effects of increasing the magnitude of an alternative reinforcer on drug choice in a discrete-trials choice procedure. Psychopharmacology 105:169–174Google Scholar
- Sarter M, Bruno JP (2002) Animal models in biological psychiatry. In: D'haenen H, den Boer JA, Willner P (eds) Biological psychiatry. Wiley, New York, pp 37–44Google Scholar
- Schmidt LG, Kuhn S, Smolka M, Schmidt K, Rommelspacher H (2002) Lisuride, a dopamine D2 receptor agonist, and anticraving drug expectancy as modifiers of relapse in alcohol dependence. Prog Neuro-Psychopharmacol Biol Psych 26:209–217Google Scholar
- Shaham Y, Shalev U, Lu L, de Wit H, Stewart J (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology DOI 10.1007/s00213-002-1224-xGoogle Scholar
- Sidman M (1960) Tactics of scientific research: evaluating experimental data in psychology. Basic Books, New YorkGoogle Scholar